These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 4001728)

  • 1. Theoretical aspects of rubella vaccination strategies.
    Knox EG
    Rev Infect Dis; 1985; 7 Suppl 1():S194-7. PubMed ID: 4001728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rubella antibody titers in vaccinated and nonvaccinated women and results of vaccination during pregnancy.
    Enders G
    Rev Infect Dis; 1985; 7 Suppl 1():S103-7. PubMed ID: 4001718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benefit-cost aspects of rubella immunization.
    Schoenbaum SC
    Rev Infect Dis; 1985; 7 Suppl 1():S210-1. PubMed ID: 3923595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of different strategies for prevention of congenital rubella infection: a practical example from Iceland.
    Gudnadóttir M
    Rev Infect Dis; 1985; 7 Suppl 1():S200-9. PubMed ID: 3923594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative investigations of different vaccination policies for the control of congenital rubella syndrome (CRS) in the United Kingdom.
    Anderson RM; Grenfell BT
    J Hyg (Lond); 1986 Apr; 96(2):305-33. PubMed ID: 3701044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccination against rubella in Britain: benefits and risks.
    Freestone DS
    Dev Biol Stand; 1979; 43():339-48. PubMed ID: 520680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of the congenital rubella syndrome: the Israeli experience.
    Fogel A; Gerichter CB; Goldblum N
    Prog Clin Biol Res; 1985; 163B():327-32. PubMed ID: 3983160
    [No Abstract]   [Full Text] [Related]  

  • 8. Safety profile of rubella vaccine administered to pregnant women: A systematic review of pregnancy related adverse events following immunisation, including congenital rubella syndrome and congenital rubella infection in the foetus or infant.
    Mangtani P; Evans SJW; Lange B; Oberle D; Smith J; Drechsel-Baeuerle U; Keller-Stanislawski B
    Vaccine; 2020 Jan; 38(5):963-978. PubMed ID: 31839467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology of congenital rubella and results of rubella vaccination in Australia.
    Menser MA; Hudson JR; Murphy AM; Upfold LJ
    Rev Infect Dis; 1985; 7 Suppl 1():S37-41. PubMed ID: 3890106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computer assessment of alternative rubella vaccination strategies in New Zealand.
    Riseley RC; Smith AH; Laugesen M; Chapman CJ
    N Z Med J; 1983 Apr; 96(729):235-8. PubMed ID: 6572834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prevention of congenital malformations caused by rubella].
    Giuliani G
    Minerva Med; 1971 May; 62(40 Suppl):9-12. PubMed ID: 5555951
    [No Abstract]   [Full Text] [Related]  

  • 12. Rubella vaccination of unknowingly pregnant women: the São Paulo experience, 2001.
    Sato HK; Sanajotta AT; Moraes JC; Andrade JQ; Duarte G; Cervi MC; Curti SP; Pannuti CS; Milanez H; Pessoto M; Flannery B; Oselka GW;
    J Infect Dis; 2011 Sep; 204 Suppl 2():S737-44. PubMed ID: 21954275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of congenital rubella and congenital varicella in Europe.
    Pandolfi E; Chiaradia G; Moncada M; Rava L; Tozzi AE
    Euro Surveill; 2009 Mar; 14(9):16-20. PubMed ID: 19317971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rubella vaccination.
    Forster J
    Eur J Pediatr; 1988 Aug; 147(6):570-3. PubMed ID: 3053188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rubella: the challenge of its control.
    Horstmann DM
    J Infect Dis; 1971 Jun; 123(6):640-54. PubMed ID: 4938949
    [No Abstract]   [Full Text] [Related]  

  • 16. Developing rubella vaccination policy in Nepal--results from rubella surveillance and seroprevalence and congenital rubella syndrome studies.
    Upreti SR; Thapa K; Pradhan YV; Shakya G; Sapkota YD; Anand A; Taylor T; Mach O; Reef S; Pattamadilok S; Liyanage J; O'Connor P; Sedai T; Bhandary SR; Partridge J; Schluter W
    J Infect Dis; 2011 Jul; 204 Suppl 1():S433-8. PubMed ID: 21666196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benefit-cost analysis of rubella vaccination policy.
    Schoenbaum SC; Hyde JN Jr Bartoshesky L; Crampton K
    N Engl J Med; 1976 Feb; 294(6):306-10. PubMed ID: 813141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fetal risk associated with rubella vaccine: an update.
    Bart SW; Stetler HC; Preblud SR; Williams NM; Orenstein WA; Bart KJ; Hinman AR; Herrmann KL
    Rev Infect Dis; 1985; 7 Suppl 1():S95-102. PubMed ID: 4001743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Follow-up study of unknowingly pregnant women vaccinated against rubella in Brazil, 2001-2002.
    Soares RC; Siqueira MM; Toscano CM; Maia Mde L; Flannery B; Sato HK; Will RM; Rodrigues RC; Oliveira IC; Barbosa TC; Sá GR; Rego MF; Curti SP; Lemos XR; Morhdieck R; Stürmer D; Oliveira MJ; Barbosa da Silva Junior J; Castillo-Solórzano C; Camacho LA; Luna E
    J Infect Dis; 2011 Sep; 204 Suppl 2():S729-36. PubMed ID: 21954274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rubella immunization strategies in Canada.
    Furesz J; Varughese P; Acres SE; Davies JW
    Rev Infect Dis; 1985; 7 Suppl 1():S191-3. PubMed ID: 4001727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.